Cargando…

MRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort

BACKGROUND: Since the application of MRI scanning to the diagnosis and treatment of multiple sclerosis, it has been recognized that only a small fraction of lesions seen on MRI scans produce recognizable symptoms or neurological findings. Because new lesions may occur without clinical detection, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cohan, Stanley, Chen, Chiayi, Baraban, Elizabeth, Stuchiner, Tamela, Grote, Lois
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034445/ https://www.ncbi.nlm.nih.gov/pubmed/27658385 http://dx.doi.org/10.1186/s12883-016-0699-8

Ejemplares similares

Results of sustained long-term use of interferon beta-1a in a community-based cohort of patients with relapsing multiple sclerosis
por: Cohan, Stanley, et al.
Publicado: (2015)

Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study
por: Smoot, Kyle, et al.
Publicado: (2021)

Quality of life among injectable and oral disease-modifying therapy users in the Pacific Northwest Multiple Sclerosis Registry
por: Stuchiner, Tamela, et al.
Publicado: (2020)

Advancing Care and Outcomes for African American Patients With Multiple Sclerosis
por: Okai, Annette F., et al.
Publicado: (2022)

The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide
por: Cohan, Stanley, et al.
Publicado: (2021)

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article
por: Cohan, Stanley, et al.
Publicado: (2020)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
por: Cohan, Stanley
Publicado: (2016)

Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy
por: Cohan, Stanley L, et al.
Publicado: (2019)

Acute Lymphoblastic Leukemia in a Man Treated With Fingolimod for Relapsing Multiple Sclerosis
por: Cohan, Stanley, et al.
Publicado: (2015)

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study
por: Cohan, Stanley, et al.
Publicado: (2018)

Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study
por: Pratap, Abhishek, et al.
Publicado: (2020)

Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND
por: Repovic, Pavle, et al.
Publicado: (2020)

The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
por: Cohan, Stanley L., et al.
Publicado: (2022)

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison
por: Cohan, Stanley, et al.
Publicado: (2021)

Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION―A 2-Year, Multicenter, Observational, Cohort Study
por: Butzkueven, Helmut, et al.
Publicado: (2022)

MRI Texture Analysis in Multiple Sclerosis
por: Zhang, Yunyan
Publicado: (2012)

Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI
por: Wen, Jie, et al.
Publicado: (2015)

Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis
por: Pinter, Daniela, et al.
Publicado: (2016)

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
por: Motyl, Jiri, et al.
Publicado: (2021)

Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis
por: Cohan, Stanley L., et al.
Publicado: (2019)

Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study
por: Buttmann, Mathias, et al.
Publicado: (2016)

“Stable” vs. “silent progressive multiple sclerosis”: a real-world retrospective clinical imaging Brazilian study
por: FIGUEIRA, Gustavo Medeiros Andrade, et al.
Publicado: (2022)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Microchimerism in multiple sclerosis: The association between sex of offspring and MRI features in women with multiple sclerosis
por: Bianchi, Alessia, et al.
Publicado: (2023)

Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study
por: Benedict, Ralph HB, et al.
Publicado: (2017)

Health service utilization in immigrants with multiple sclerosis
por: Rotstein, Dalia L., et al.
Publicado: (2020)

Utility of shape evolution and displacement in the classification of chronic multiple sclerosis lesions
por: Okuda, Darin T., et al.
Publicado: (2020)

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
por: Cohan, Stanley L., et al.
Publicado: (2021)

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
por: Behrens, Janina R., et al.
Publicado: (2018)

MRI Correlates of Disability in African-Americans with Multiple Sclerosis
por: Howard, Jonathan, et al.
Publicado: (2012)

Determinants of Disability in Multiple Sclerosis: An Immunological and MRI Study
por: Tortorella, Paola, et al.
Publicado: (2014)

Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis
por: Healy, Brian C., et al.
Publicado: (2017)

Structural MRI correlates of PASAT performance in multiple sclerosis
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Diagnosis and management of multiple sclerosis: MRI in clinical practice
por: Tomassini, Valentina, et al.
Publicado: (2020)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

Racial disparities in Medicaid home and community-based service utilization and expenditures among persons with multiple sclerosis
por: Fabius, Chanee D, et al.
Publicado: (2018)

Impact on healthcare resource utilization of multiple sclerosis in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

The utility of Magnetoencephalography in multiple sclerosis – A systematic review
por: Khan, H., et al.
Publicado: (2021)

Utility of the visual system to monitor neurodegeneration in multiple sclerosis
por: Mey, Gabrielle M., et al.
Publicado: (2023)

Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
por: Raffel, Joel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hl39a73o057qoiamk44svi9v7r